nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CHRM3—Carbachol—glaucoma	0.13	0.17	CbGbCtD
Solifenacin—CHRM3—Pilocarpine—glaucoma	0.121	0.158	CbGbCtD
Solifenacin—CHRM1—Carbachol—glaucoma	0.113	0.148	CbGbCtD
Solifenacin—CHRM1—Pilocarpine—glaucoma	0.105	0.137	CbGbCtD
Solifenacin—CHRM2—Carbachol—glaucoma	0.104	0.136	CbGbCtD
Solifenacin—CHRM2—Pilocarpine—glaucoma	0.097	0.127	CbGbCtD
Solifenacin—CYP3A4—Pilocarpine—glaucoma	0.0225	0.0294	CbGbCtD
Solifenacin—CYP3A4—Brinzolamide—glaucoma	0.0176	0.023	CbGbCtD
Solifenacin—CYP3A4—Dorzolamide—glaucoma	0.017	0.0222	CbGbCtD
Solifenacin—CYP3A4—Methazolamide—glaucoma	0.0152	0.0198	CbGbCtD
Solifenacin—CYP3A4—Acetazolamide—glaucoma	0.0121	0.0158	CbGbCtD
Solifenacin—CYP3A4—Clonidine—glaucoma	0.011	0.0143	CbGbCtD
Solifenacin—Benazepril—MTHFR—glaucoma	0.00226	1	CrCbGaD
Solifenacin—Dry mouth—Travoprost—glaucoma	0.00035	0.00157	CcSEcCtD
Solifenacin—Cough—Pilocarpine—glaucoma	0.000348	0.00156	CcSEcCtD
Solifenacin—Dizziness—Latanoprost—glaucoma	0.000348	0.00156	CcSEcCtD
Solifenacin—Confusional state—Dorzolamide—glaucoma	0.000348	0.00155	CcSEcCtD
Solifenacin—Liver function test abnormal—Timolol—glaucoma	0.000348	0.00155	CcSEcCtD
Solifenacin—Feeling abnormal—Apraclonidine—glaucoma	0.000346	0.00155	CcSEcCtD
Solifenacin—Dry mouth—Brinzolamide—glaucoma	0.000346	0.00155	CcSEcCtD
Solifenacin—Vomiting—Methazolamide—glaucoma	0.000345	0.00155	CcSEcCtD
Solifenacin—Anaphylactic shock—Dorzolamide—glaucoma	0.000345	0.00154	CcSEcCtD
Solifenacin—Hypertension—Pilocarpine—glaucoma	0.000345	0.00154	CcSEcCtD
Solifenacin—Gastrointestinal pain—Apraclonidine—glaucoma	0.000344	0.00154	CcSEcCtD
Solifenacin—Abdominal pain upper—Timolol—glaucoma	0.000344	0.00154	CcSEcCtD
Solifenacin—Rash—Methazolamide—glaucoma	0.000343	0.00153	CcSEcCtD
Solifenacin—Dermatitis—Methazolamide—glaucoma	0.000342	0.00153	CcSEcCtD
Solifenacin—Eye disorder—Clonidine—glaucoma	0.000342	0.00153	CcSEcCtD
Solifenacin—Nausea—Carbachol—glaucoma	0.000342	0.00153	CcSEcCtD
Solifenacin—Infection—Travoprost—glaucoma	0.000341	0.00153	CcSEcCtD
Solifenacin—Headache—Methazolamide—glaucoma	0.00034	0.00152	CcSEcCtD
Solifenacin—Cardiac disorder—Clonidine—glaucoma	0.00034	0.00152	CcSEcCtD
Solifenacin—Nausea—Levobunolol—glaucoma	0.000337	0.00151	CcSEcCtD
Solifenacin—Infection—Brinzolamide—glaucoma	0.000337	0.00151	CcSEcCtD
Solifenacin—Nervous system disorder—Travoprost—glaucoma	0.000337	0.00151	CcSEcCtD
Solifenacin—Tachycardia—Travoprost—glaucoma	0.000335	0.0015	CcSEcCtD
Solifenacin—Somnolence—Acetazolamide—glaucoma	0.000334	0.0015	CcSEcCtD
Solifenacin—Skin disorder—Travoprost—glaucoma	0.000333	0.00149	CcSEcCtD
Solifenacin—Abdominal pain—Apraclonidine—glaucoma	0.000332	0.00149	CcSEcCtD
Solifenacin—Nervous system disorder—Brinzolamide—glaucoma	0.000332	0.00149	CcSEcCtD
Solifenacin—Angiopathy—Clonidine—glaucoma	0.000332	0.00149	CcSEcCtD
Solifenacin—Rash—Latanoprost—glaucoma	0.000332	0.00148	CcSEcCtD
Solifenacin—Dermatitis—Latanoprost—glaucoma	0.000331	0.00148	CcSEcCtD
Solifenacin—Dyspepsia—Acetazolamide—glaucoma	0.000331	0.00148	CcSEcCtD
Solifenacin—Tachycardia—Brinzolamide—glaucoma	0.000331	0.00148	CcSEcCtD
Solifenacin—Mediastinal disorder—Clonidine—glaucoma	0.00033	0.00148	CcSEcCtD
Solifenacin—Headache—Latanoprost—glaucoma	0.000329	0.00147	CcSEcCtD
Solifenacin—Skin disorder—Brinzolamide—glaucoma	0.000329	0.00147	CcSEcCtD
Solifenacin—Confusional state—Pilocarpine—glaucoma	0.000328	0.00147	CcSEcCtD
Solifenacin—Decreased appetite—Acetazolamide—glaucoma	0.000327	0.00146	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000325	0.00145	CcSEcCtD
Solifenacin—Fatigue—Acetazolamide—glaucoma	0.000324	0.00145	CcSEcCtD
Solifenacin—Infection—Pilocarpine—glaucoma	0.000324	0.00145	CcSEcCtD
Solifenacin—Nausea—Methazolamide—glaucoma	0.000323	0.00144	CcSEcCtD
Solifenacin—Somnolence—Brimonidine—glaucoma	0.000321	0.00144	CcSEcCtD
Solifenacin—Mental disorder—Clonidine—glaucoma	0.000321	0.00143	CcSEcCtD
Solifenacin—Tachycardia—Pilocarpine—glaucoma	0.000318	0.00142	CcSEcCtD
Solifenacin—Dyspepsia—Brimonidine—glaucoma	0.000318	0.00142	CcSEcCtD
Solifenacin—Hallucination—Betaxolol—glaucoma	0.000317	0.00142	CcSEcCtD
Solifenacin—Pharyngitis—Betaxolol—glaucoma	0.000316	0.00142	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Brimonidine—glaucoma	0.000312	0.00139	CcSEcCtD
Solifenacin—Fatigue—Brimonidine—glaucoma	0.000311	0.00139	CcSEcCtD
Solifenacin—Feeling abnormal—Acetazolamide—glaucoma	0.00031	0.00139	CcSEcCtD
Solifenacin—Hypersensitivity—Apraclonidine—glaucoma	0.00031	0.00139	CcSEcCtD
Solifenacin—Somnolence—Dorzolamide—glaucoma	0.000306	0.00137	CcSEcCtD
Solifenacin—Dysuria—Timolol—glaucoma	0.000304	0.00136	CcSEcCtD
Solifenacin—Dyspepsia—Dorzolamide—glaucoma	0.000303	0.00136	CcSEcCtD
Solifenacin—Dyspepsia—Travoprost—glaucoma	0.000302	0.00135	CcSEcCtD
Solifenacin—Asthenia—Apraclonidine—glaucoma	0.000302	0.00135	CcSEcCtD
Solifenacin—Somnolence—Brinzolamide—glaucoma	0.000301	0.00135	CcSEcCtD
Solifenacin—Vision blurred—Clonidine—glaucoma	0.0003	0.00134	CcSEcCtD
Solifenacin—Decreased appetite—Dorzolamide—glaucoma	0.0003	0.00134	CcSEcCtD
Solifenacin—Urticaria—Acetazolamide—glaucoma	0.000299	0.00134	CcSEcCtD
Solifenacin—Dyspepsia—Brinzolamide—glaucoma	0.000298	0.00133	CcSEcCtD
Solifenacin—Eye disorder—Betaxolol—glaucoma	0.000298	0.00133	CcSEcCtD
Solifenacin—Pruritus—Apraclonidine—glaucoma	0.000297	0.00133	CcSEcCtD
Solifenacin—Fatigue—Dorzolamide—glaucoma	0.000297	0.00133	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Travoprost—glaucoma	0.000296	0.00133	CcSEcCtD
Solifenacin—Fatigue—Travoprost—glaucoma	0.000296	0.00132	CcSEcCtD
Solifenacin—Cardiac disorder—Betaxolol—glaucoma	0.000296	0.00132	CcSEcCtD
Solifenacin—Decreased appetite—Brinzolamide—glaucoma	0.000295	0.00132	CcSEcCtD
Solifenacin—Constipation—Travoprost—glaucoma	0.000294	0.00131	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000293	0.00131	CcSEcCtD
Solifenacin—Asthenia—Bimatoprost—glaucoma	0.000292	0.00131	CcSEcCtD
Solifenacin—Fatigue—Brinzolamide—glaucoma	0.000292	0.00131	CcSEcCtD
Solifenacin—Angioedema—Clonidine—glaucoma	0.000291	0.0013	CcSEcCtD
Solifenacin—Somnolence—Pilocarpine—glaucoma	0.00029	0.0013	CcSEcCtD
Solifenacin—Depression—Timolol—glaucoma	0.000289	0.00129	CcSEcCtD
Solifenacin—Angiopathy—Betaxolol—glaucoma	0.000289	0.00129	CcSEcCtD
Solifenacin—Pruritus—Bimatoprost—glaucoma	0.000288	0.00129	CcSEcCtD
Solifenacin—Immune system disorder—Betaxolol—glaucoma	0.000288	0.00129	CcSEcCtD
Solifenacin—Mediastinal disorder—Betaxolol—glaucoma	0.000287	0.00128	CcSEcCtD
Solifenacin—Dyspepsia—Pilocarpine—glaucoma	0.000287	0.00128	CcSEcCtD
Solifenacin—Feeling abnormal—Dorzolamide—glaucoma	0.000284	0.00127	CcSEcCtD
Solifenacin—Decreased appetite—Pilocarpine—glaucoma	0.000283	0.00127	CcSEcCtD
Solifenacin—Feeling abnormal—Travoprost—glaucoma	0.000283	0.00127	CcSEcCtD
Solifenacin—Gastrointestinal pain—Dorzolamide—glaucoma	0.000282	0.00126	CcSEcCtD
Solifenacin—Palpitations—Clonidine—glaucoma	0.000282	0.00126	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000281	0.00126	CcSEcCtD
Solifenacin—Gastrointestinal pain—Travoprost—glaucoma	0.000281	0.00126	CcSEcCtD
Solifenacin—Feeling abnormal—Brinzolamide—glaucoma	0.000279	0.00125	CcSEcCtD
Solifenacin—Mental disorder—Betaxolol—glaucoma	0.000279	0.00125	CcSEcCtD
Solifenacin—Constipation—Pilocarpine—glaucoma	0.000279	0.00125	CcSEcCtD
Solifenacin—Cough—Clonidine—glaucoma	0.000278	0.00124	CcSEcCtD
Solifenacin—Dizziness—Apraclonidine—glaucoma	0.000278	0.00124	CcSEcCtD
Solifenacin—Malnutrition—Betaxolol—glaucoma	0.000277	0.00124	CcSEcCtD
Solifenacin—Urticaria—Dorzolamide—glaucoma	0.000274	0.00122	CcSEcCtD
Solifenacin—Abdominal pain—Dorzolamide—glaucoma	0.000272	0.00122	CcSEcCtD
Solifenacin—Dysgeusia—Betaxolol—glaucoma	0.000272	0.00122	CcSEcCtD
Solifenacin—Abdominal pain—Travoprost—glaucoma	0.000271	0.00121	CcSEcCtD
Solifenacin—Asthenia—Acetazolamide—glaucoma	0.00027	0.00121	CcSEcCtD
Solifenacin—Dizziness—Bimatoprost—glaucoma	0.00027	0.00121	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000269	0.00121	CcSEcCtD
Solifenacin—Urticaria—Brinzolamide—glaucoma	0.000269	0.0012	CcSEcCtD
Solifenacin—Feeling abnormal—Pilocarpine—glaucoma	0.000268	0.0012	CcSEcCtD
Solifenacin—Vomiting—Apraclonidine—glaucoma	0.000267	0.0012	CcSEcCtD
Solifenacin—Gastrointestinal pain—Pilocarpine—glaucoma	0.000266	0.00119	CcSEcCtD
Solifenacin—Hypersensitivity—Brimonidine—glaucoma	0.000266	0.00119	CcSEcCtD
Solifenacin—Dry mouth—Clonidine—glaucoma	0.000265	0.00119	CcSEcCtD
Solifenacin—Dermatitis—Apraclonidine—glaucoma	0.000265	0.00118	CcSEcCtD
Solifenacin—Headache—Apraclonidine—glaucoma	0.000263	0.00118	CcSEcCtD
Solifenacin—Confusional state—Clonidine—glaucoma	0.000262	0.00117	CcSEcCtD
Solifenacin—Vision blurred—Betaxolol—glaucoma	0.000262	0.00117	CcSEcCtD
Solifenacin—Hallucination—Timolol—glaucoma	0.000259	0.00116	CcSEcCtD
Solifenacin—Asthenia—Brimonidine—glaucoma	0.000259	0.00116	CcSEcCtD
Solifenacin—Infection—Clonidine—glaucoma	0.000258	0.00116	CcSEcCtD
Solifenacin—Abdominal pain—Pilocarpine—glaucoma	0.000257	0.00115	CcSEcCtD
Solifenacin—Rash—Bimatoprost—glaucoma	0.000257	0.00115	CcSEcCtD
Solifenacin—Dermatitis—Bimatoprost—glaucoma	0.000257	0.00115	CcSEcCtD
Solifenacin—Oedema peripheral—Timolol—glaucoma	0.000257	0.00115	CcSEcCtD
Solifenacin—Connective tissue disorder—Timolol—glaucoma	0.000256	0.00114	CcSEcCtD
Solifenacin—Pruritus—Brimonidine—glaucoma	0.000255	0.00114	CcSEcCtD
Solifenacin—Headache—Bimatoprost—glaucoma	0.000255	0.00114	CcSEcCtD
Solifenacin—Nervous system disorder—Clonidine—glaucoma	0.000255	0.00114	CcSEcCtD
Solifenacin—Hypersensitivity—Dorzolamide—glaucoma	0.000254	0.00114	CcSEcCtD
Solifenacin—Tachycardia—Clonidine—glaucoma	0.000254	0.00114	CcSEcCtD
Solifenacin—Hypersensitivity—Travoprost—glaucoma	0.000253	0.00113	CcSEcCtD
Solifenacin—Skin disorder—Clonidine—glaucoma	0.000253	0.00113	CcSEcCtD
Solifenacin—Nausea—Apraclonidine—glaucoma	0.00025	0.00112	CcSEcCtD
Solifenacin—Hypersensitivity—Brinzolamide—glaucoma	0.00025	0.00112	CcSEcCtD
Solifenacin—Dizziness—Acetazolamide—glaucoma	0.000249	0.00111	CcSEcCtD
Solifenacin—Asthenia—Dorzolamide—glaucoma	0.000247	0.00111	CcSEcCtD
Solifenacin—Asthenia—Travoprost—glaucoma	0.000246	0.0011	CcSEcCtD
Solifenacin—Palpitations—Betaxolol—glaucoma	0.000245	0.0011	CcSEcCtD
Solifenacin—Pruritus—Dorzolamide—glaucoma	0.000244	0.00109	CcSEcCtD
Solifenacin—Eye disorder—Timolol—glaucoma	0.000243	0.00109	CcSEcCtD
Solifenacin—Asthenia—Brinzolamide—glaucoma	0.000243	0.00109	CcSEcCtD
Solifenacin—Pruritus—Travoprost—glaucoma	0.000243	0.00109	CcSEcCtD
Solifenacin—Cough—Betaxolol—glaucoma	0.000242	0.00108	CcSEcCtD
Solifenacin—Nausea—Bimatoprost—glaucoma	0.000242	0.00108	CcSEcCtD
Solifenacin—Cardiac disorder—Timolol—glaucoma	0.000242	0.00108	CcSEcCtD
Solifenacin—Hypersensitivity—Pilocarpine—glaucoma	0.00024	0.00107	CcSEcCtD
Solifenacin—Pruritus—Brinzolamide—glaucoma	0.00024	0.00107	CcSEcCtD
Solifenacin—Vomiting—Acetazolamide—glaucoma	0.000239	0.00107	CcSEcCtD
Solifenacin—Dizziness—Brimonidine—glaucoma	0.000239	0.00107	CcSEcCtD
Solifenacin—Angiopathy—Timolol—glaucoma	0.000236	0.00106	CcSEcCtD
Solifenacin—Headache—Acetazolamide—glaucoma	0.000236	0.00105	CcSEcCtD
Solifenacin—Immune system disorder—Timolol—glaucoma	0.000235	0.00105	CcSEcCtD
Solifenacin—Mediastinal disorder—Timolol—glaucoma	0.000235	0.00105	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000235	0.00105	CcSEcCtD
Solifenacin—Asthenia—Pilocarpine—glaucoma	0.000234	0.00105	CcSEcCtD
Solifenacin—Somnolence—Clonidine—glaucoma	0.000231	0.00103	CcSEcCtD
Solifenacin—Dry mouth—Betaxolol—glaucoma	0.000231	0.00103	CcSEcCtD
Solifenacin—Pruritus—Pilocarpine—glaucoma	0.00023	0.00103	CcSEcCtD
Solifenacin—Confusional state—Betaxolol—glaucoma	0.000228	0.00102	CcSEcCtD
Solifenacin—Mental disorder—Timolol—glaucoma	0.000228	0.00102	CcSEcCtD
Solifenacin—Dizziness—Dorzolamide—glaucoma	0.000228	0.00102	CcSEcCtD
Solifenacin—Rash—Brimonidine—glaucoma	0.000228	0.00102	CcSEcCtD
Solifenacin—Dermatitis—Brimonidine—glaucoma	0.000227	0.00102	CcSEcCtD
Solifenacin—Dizziness—Travoprost—glaucoma	0.000227	0.00102	CcSEcCtD
Solifenacin—Malnutrition—Timolol—glaucoma	0.000227	0.00101	CcSEcCtD
Solifenacin—Headache—Brimonidine—glaucoma	0.000226	0.00101	CcSEcCtD
Solifenacin—Decreased appetite—Clonidine—glaucoma	0.000226	0.00101	CcSEcCtD
Solifenacin—Infection—Betaxolol—glaucoma	0.000225	0.00101	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Clonidine—glaucoma	0.000225	0.001	CcSEcCtD
Solifenacin—Fatigue—Clonidine—glaucoma	0.000224	0.001	CcSEcCtD
Solifenacin—Dizziness—Brinzolamide—glaucoma	0.000224	0.001	CcSEcCtD
Solifenacin—Nausea—Acetazolamide—glaucoma	0.000223	0.000999	CcSEcCtD
Solifenacin—Constipation—Clonidine—glaucoma	0.000222	0.000995	CcSEcCtD
Solifenacin—Nervous system disorder—Betaxolol—glaucoma	0.000222	0.000993	CcSEcCtD
Solifenacin—Dysgeusia—Timolol—glaucoma	0.000222	0.000993	CcSEcCtD
Solifenacin—Tachycardia—Betaxolol—glaucoma	0.000221	0.000989	CcSEcCtD
Solifenacin—Skin disorder—Betaxolol—glaucoma	0.00022	0.000984	CcSEcCtD
Solifenacin—Vomiting—Dorzolamide—glaucoma	0.000219	0.00098	CcSEcCtD
Solifenacin—Rash—Dorzolamide—glaucoma	0.000217	0.000972	CcSEcCtD
Solifenacin—Dermatitis—Dorzolamide—glaucoma	0.000217	0.000971	CcSEcCtD
Solifenacin—Rash—Travoprost—glaucoma	0.000216	0.000968	CcSEcCtD
Solifenacin—Dermatitis—Travoprost—glaucoma	0.000216	0.000967	CcSEcCtD
Solifenacin—Headache—Dorzolamide—glaucoma	0.000216	0.000966	CcSEcCtD
Solifenacin—Vomiting—Brinzolamide—glaucoma	0.000215	0.000964	CcSEcCtD
Solifenacin—Dizziness—Pilocarpine—glaucoma	0.000215	0.000963	CcSEcCtD
Solifenacin—Headache—Travoprost—glaucoma	0.000215	0.000962	CcSEcCtD
Solifenacin—Nausea—Brimonidine—glaucoma	0.000214	0.000959	CcSEcCtD
Solifenacin—Feeling abnormal—Clonidine—glaucoma	0.000214	0.000959	CcSEcCtD
Solifenacin—Rash—Brinzolamide—glaucoma	0.000214	0.000956	CcSEcCtD
Solifenacin—Vision blurred—Timolol—glaucoma	0.000214	0.000956	CcSEcCtD
Solifenacin—Dermatitis—Brinzolamide—glaucoma	0.000213	0.000955	CcSEcCtD
Solifenacin—Gastrointestinal pain—Clonidine—glaucoma	0.000213	0.000951	CcSEcCtD
Solifenacin—Headache—Brinzolamide—glaucoma	0.000212	0.00095	CcSEcCtD
Solifenacin—Angioedema—Timolol—glaucoma	0.000207	0.000926	CcSEcCtD
Solifenacin—Vomiting—Pilocarpine—glaucoma	0.000207	0.000926	CcSEcCtD
Solifenacin—Urticaria—Clonidine—glaucoma	0.000207	0.000924	CcSEcCtD
Solifenacin—Abdominal pain—Clonidine—glaucoma	0.000206	0.00092	CcSEcCtD
Solifenacin—Rash—Pilocarpine—glaucoma	0.000205	0.000919	CcSEcCtD
Solifenacin—Dermatitis—Pilocarpine—glaucoma	0.000205	0.000918	CcSEcCtD
Solifenacin—Nausea—Dorzolamide—glaucoma	0.000205	0.000916	CcSEcCtD
Solifenacin—Headache—Pilocarpine—glaucoma	0.000204	0.000913	CcSEcCtD
Solifenacin—Nausea—Travoprost—glaucoma	0.000204	0.000912	CcSEcCtD
Solifenacin—Nausea—Brinzolamide—glaucoma	0.000201	0.0009	CcSEcCtD
Solifenacin—Palpitations—Timolol—glaucoma	0.0002	0.000896	CcSEcCtD
Solifenacin—Dyspepsia—Betaxolol—glaucoma	0.000199	0.000892	CcSEcCtD
Solifenacin—Cough—Timolol—glaucoma	0.000198	0.000885	CcSEcCtD
Solifenacin—Decreased appetite—Betaxolol—glaucoma	0.000197	0.000881	CcSEcCtD
Solifenacin—Hypertension—Timolol—glaucoma	0.000196	0.000875	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Betaxolol—glaucoma	0.000196	0.000875	CcSEcCtD
Solifenacin—Fatigue—Betaxolol—glaucoma	0.000195	0.000873	CcSEcCtD
Solifenacin—Constipation—Betaxolol—glaucoma	0.000194	0.000866	CcSEcCtD
Solifenacin—Nausea—Pilocarpine—glaucoma	0.000193	0.000865	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000192	0.000857	CcSEcCtD
Solifenacin—Hypersensitivity—Clonidine—glaucoma	0.000192	0.000857	CcSEcCtD
Solifenacin—Dry mouth—Timolol—glaucoma	0.000189	0.000844	CcSEcCtD
Solifenacin—Asthenia—Clonidine—glaucoma	0.000187	0.000835	CcSEcCtD
Solifenacin—Feeling abnormal—Betaxolol—glaucoma	0.000187	0.000835	CcSEcCtD
Solifenacin—Confusional state—Timolol—glaucoma	0.000187	0.000834	CcSEcCtD
Solifenacin—Anaphylactic shock—Timolol—glaucoma	0.000185	0.000828	CcSEcCtD
Solifenacin—Pruritus—Clonidine—glaucoma	0.000184	0.000823	CcSEcCtD
Solifenacin—Infection—Timolol—glaucoma	0.000184	0.000822	CcSEcCtD
Solifenacin—Nervous system disorder—Timolol—glaucoma	0.000181	0.000812	CcSEcCtD
Solifenacin—Urticaria—Betaxolol—glaucoma	0.00018	0.000805	CcSEcCtD
Solifenacin—Skin disorder—Timolol—glaucoma	0.00018	0.000804	CcSEcCtD
Solifenacin—Dizziness—Clonidine—glaucoma	0.000172	0.000769	CcSEcCtD
Solifenacin—Hypersensitivity—Betaxolol—glaucoma	0.000167	0.000746	CcSEcCtD
Solifenacin—Vomiting—Clonidine—glaucoma	0.000165	0.00074	CcSEcCtD
Solifenacin—Somnolence—Timolol—glaucoma	0.000164	0.000736	CcSEcCtD
Solifenacin—Rash—Clonidine—glaucoma	0.000164	0.000734	CcSEcCtD
Solifenacin—Dermatitis—Clonidine—glaucoma	0.000164	0.000733	CcSEcCtD
Solifenacin—Headache—Clonidine—glaucoma	0.000163	0.000729	CcSEcCtD
Solifenacin—Dyspepsia—Timolol—glaucoma	0.000163	0.000728	CcSEcCtD
Solifenacin—Asthenia—Betaxolol—glaucoma	0.000162	0.000727	CcSEcCtD
Solifenacin—Decreased appetite—Timolol—glaucoma	0.000161	0.000719	CcSEcCtD
Solifenacin—Pruritus—Betaxolol—glaucoma	0.00016	0.000717	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Timolol—glaucoma	0.00016	0.000714	CcSEcCtD
Solifenacin—Fatigue—Timolol—glaucoma	0.000159	0.000713	CcSEcCtD
Solifenacin—Nausea—Clonidine—glaucoma	0.000155	0.000691	CcSEcCtD
Solifenacin—Feeling abnormal—Timolol—glaucoma	0.000152	0.000682	CcSEcCtD
Solifenacin—Gastrointestinal pain—Timolol—glaucoma	0.000151	0.000677	CcSEcCtD
Solifenacin—Dizziness—Betaxolol—glaucoma	0.00015	0.00067	CcSEcCtD
Solifenacin—Urticaria—Timolol—glaucoma	0.000147	0.000657	CcSEcCtD
Solifenacin—Abdominal pain—Timolol—glaucoma	0.000146	0.000654	CcSEcCtD
Solifenacin—Vomiting—Betaxolol—glaucoma	0.000144	0.000644	CcSEcCtD
Solifenacin—Rash—Betaxolol—glaucoma	0.000143	0.000639	CcSEcCtD
Solifenacin—Dermatitis—Betaxolol—glaucoma	0.000143	0.000638	CcSEcCtD
Solifenacin—Headache—Betaxolol—glaucoma	0.000142	0.000635	CcSEcCtD
Solifenacin—Hypersensitivity—Timolol—glaucoma	0.000136	0.00061	CcSEcCtD
Solifenacin—Nausea—Betaxolol—glaucoma	0.000135	0.000602	CcSEcCtD
Solifenacin—Asthenia—Timolol—glaucoma	0.000133	0.000594	CcSEcCtD
Solifenacin—Pruritus—Timolol—glaucoma	0.000131	0.000585	CcSEcCtD
Solifenacin—Dizziness—Timolol—glaucoma	0.000122	0.000547	CcSEcCtD
Solifenacin—Vomiting—Timolol—glaucoma	0.000118	0.000526	CcSEcCtD
Solifenacin—Rash—Timolol—glaucoma	0.000117	0.000522	CcSEcCtD
Solifenacin—Dermatitis—Timolol—glaucoma	0.000117	0.000521	CcSEcCtD
Solifenacin—Headache—Timolol—glaucoma	0.000116	0.000518	CcSEcCtD
Solifenacin—Nausea—Timolol—glaucoma	0.00011	0.000492	CcSEcCtD
Solifenacin—CHRM4—GPCR downstream signaling—OPN4—glaucoma	3.47e-05	0.00439	CbGpPWpGaD
Solifenacin—CHRM4—Regulation of Actin Cytoskeleton—FN1—glaucoma	3.36e-05	0.00424	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—OPN4—glaucoma	3.33e-05	0.0042	CbGpPWpGaD
Solifenacin—CHRM5—Regulation of Actin Cytoskeleton—FN1—glaucoma	3.21e-05	0.00406	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—OPN4—glaucoma	3.16e-05	0.00399	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—PTGFR—glaucoma	3.13e-05	0.00395	CbGpPWpGaD
Solifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	3.13e-05	0.00395	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—OPN4—glaucoma	3.02e-05	0.00382	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—PTGFR—glaucoma	3e-05	0.00379	CbGpPWpGaD
Solifenacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	2.94e-05	0.00372	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—BDNF—glaucoma	2.91e-05	0.00367	CbGpPWpGaD
Solifenacin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.91e-05	0.00367	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—NARFL—glaucoma	2.85e-05	0.0036	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CA5A—glaucoma	2.85e-05	0.0036	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—PTGFR—glaucoma	2.84e-05	0.00359	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—IL1A—glaucoma	2.79e-05	0.00353	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—SMO—glaucoma	2.79e-05	0.00353	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—NGFR—glaucoma	2.76e-05	0.00349	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—PTGFR—glaucoma	2.72e-05	0.00344	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—LRP12—glaucoma	2.69e-05	0.0034	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—SMO—glaucoma	2.67e-05	0.00338	CbGpPWpGaD
Solifenacin—CHRM4—G alpha (i) signalling events—C3—glaucoma	2.66e-05	0.00336	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—NTRK1—glaucoma	2.63e-05	0.00332	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—NGF—glaucoma	2.58e-05	0.00326	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—LRP12—glaucoma	2.58e-05	0.00325	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—NR3C1—glaucoma	2.57e-05	0.00325	CbGpPWpGaD
Solifenacin—CHRM1—G alpha (q) signalling events—EDN1—glaucoma	2.46e-05	0.00311	CbGpPWpGaD
Solifenacin—CHRM3—G alpha (q) signalling events—EDN1—glaucoma	2.45e-05	0.0031	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.42e-05	0.00305	CbGpPWpGaD
Solifenacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.39e-05	0.00302	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—OPN4—glaucoma	2.34e-05	0.00296	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—OPN4—glaucoma	2.34e-05	0.00295	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.31e-05	0.00292	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—OPN4—glaucoma	2.31e-05	0.00292	CbGpPWpGaD
Solifenacin—CHRM1—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.26e-05	0.00286	CbGpPWpGaD
Solifenacin—CHRM3—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.26e-05	0.00285	CbGpPWpGaD
Solifenacin—CHRM2—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.23e-05	0.00282	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.2e-05	0.00278	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.19e-05	0.00277	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—OPN4—glaucoma	2.13e-05	0.00269	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—OPN4—glaucoma	2.12e-05	0.00268	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.11e-05	0.00267	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—PTGFR—glaucoma	2.11e-05	0.00267	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—PTGFR—glaucoma	2.1e-05	0.00266	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—OPN4—glaucoma	2.1e-05	0.00265	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—PTGFR—glaucoma	2.08e-05	0.00263	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—FAS—glaucoma	2.06e-05	0.0026	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.02e-05	0.00256	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PTGFR—glaucoma	1.92e-05	0.00242	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PTGFR—glaucoma	1.91e-05	0.00241	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PTGFR—glaucoma	1.89e-05	0.00239	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—SMO—glaucoma	1.88e-05	0.00238	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—SMO—glaucoma	1.88e-05	0.00237	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—OPN4—glaucoma	1.86e-05	0.00236	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—SMO—glaucoma	1.86e-05	0.00235	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—EDN1—glaucoma	1.84e-05	0.00233	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—LRP12—glaucoma	1.81e-05	0.00229	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—LRP12—glaucoma	1.81e-05	0.00228	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—LRP12—glaucoma	1.79e-05	0.00226	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—OPN4—glaucoma	1.79e-05	0.00226	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—C3—glaucoma	1.77e-05	0.00223	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—EDN1—glaucoma	1.76e-05	0.00223	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HEYL—glaucoma	1.73e-05	0.00219	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PTGFR—glaucoma	1.68e-05	0.00212	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HEYL—glaucoma	1.66e-05	0.0021	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.63e-05	0.00206	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.62e-05	0.00205	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.61e-05	0.00203	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—C3—glaucoma	1.61e-05	0.00203	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PTGFR—glaucoma	1.61e-05	0.00203	CbGpPWpGaD
Solifenacin—CYP3A4—Biological oxidations—GSTT1—glaucoma	1.59e-05	0.00201	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—C3—glaucoma	1.54e-05	0.00195	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—SMO—glaucoma	1.43e-05	0.00181	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.42e-05	0.0018	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.42e-05	0.00179	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.41e-05	0.00178	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CA1—glaucoma	1.39e-05	0.00176	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—SMO—glaucoma	1.37e-05	0.00173	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CTSA—glaucoma	1.35e-05	0.0017	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—RPTOR—glaucoma	1.31e-05	0.00166	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CA2—glaucoma	1.27e-05	0.00161	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NCK2—glaucoma	1.27e-05	0.00161	CbGpPWpGaD
Solifenacin—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.27e-05	0.0016	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—RPTOR—glaucoma	1.26e-05	0.00159	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—OPN4—glaucoma	1.26e-05	0.00159	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—OPN4—glaucoma	1.25e-05	0.00158	CbGpPWpGaD
Solifenacin—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.25e-05	0.00158	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—EDN1—glaucoma	1.24e-05	0.00157	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—OPN4—glaucoma	1.24e-05	0.00157	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—EDN1—glaucoma	1.24e-05	0.00156	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.23e-05	0.00156	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—EDN1—glaucoma	1.23e-05	0.00155	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NCK2—glaucoma	1.22e-05	0.00154	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HEYL—glaucoma	1.17e-05	0.00148	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HEYL—glaucoma	1.16e-05	0.00147	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HEYL—glaucoma	1.15e-05	0.00146	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PTGFR—glaucoma	1.13e-05	0.00143	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PTGFR—glaucoma	1.13e-05	0.00143	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PTGFR—glaucoma	1.12e-05	0.00141	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CA5A—glaucoma	1.12e-05	0.00141	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NARFL—glaucoma	1.12e-05	0.00141	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—C3—glaucoma	1.08e-05	0.00137	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HDAC9—glaucoma	1.08e-05	0.00137	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—C3—glaucoma	1.08e-05	0.00137	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—C3—glaucoma	1.07e-05	0.00135	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	1.06e-05	0.00133	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—EDN1—glaucoma	1.04e-05	0.00131	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HDAC9—glaucoma	1.04e-05	0.00131	CbGpPWpGaD
Solifenacin—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.01e-05	0.00128	CbGpPWpGaD
Solifenacin—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1e-05	0.00126	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—EDN1—glaucoma	9.96e-06	0.00126	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—SMO—glaucoma	9.66e-06	0.00122	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—SMO—glaucoma	9.63e-06	0.00122	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—SMO—glaucoma	9.54e-06	0.0012	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—EDN1—glaucoma	9.45e-06	0.00119	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—C3—glaucoma	9.09e-06	0.00115	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—EDN1—glaucoma	9.05e-06	0.00114	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—TXN—glaucoma	8.98e-06	0.00113	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RPTOR—glaucoma	8.86e-06	0.00112	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RPTOR—glaucoma	8.83e-06	0.00112	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RPTOR—glaucoma	8.74e-06	0.0011	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—C3—glaucoma	8.7e-06	0.0011	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NCK2—glaucoma	8.58e-06	0.00108	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NCK2—glaucoma	8.55e-06	0.00108	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NCK2—glaucoma	8.47e-06	0.00107	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SMO—glaucoma	8.46e-06	0.00107	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—C3—glaucoma	8.25e-06	0.00104	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SMO—glaucoma	8.1e-06	0.00102	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—C3—glaucoma	7.9e-06	0.000998	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NTRK2—glaucoma	7.74e-06	0.000978	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—TP53—glaucoma	7.7e-06	0.000973	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NTRK2—glaucoma	7.41e-06	0.000937	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HDAC9—glaucoma	7.29e-06	0.000921	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HDAC9—glaucoma	7.27e-06	0.000919	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HDAC9—glaucoma	7.2e-06	0.00091	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—EDN1—glaucoma	7.01e-06	0.000886	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—EDN1—glaucoma	6.99e-06	0.000883	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GSTT1—glaucoma	6.96e-06	0.00088	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—EDN1—glaucoma	6.92e-06	0.000875	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NGFR—glaucoma	6.64e-06	0.000839	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—EDN1—glaucoma	6.37e-06	0.000805	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NGFR—glaucoma	6.36e-06	0.000804	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—EDN1—glaucoma	6.35e-06	0.000802	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NTRK1—glaucoma	6.31e-06	0.000797	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—EDN1—glaucoma	6.29e-06	0.000794	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—C3—glaucoma	6.13e-06	0.000774	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—C3—glaucoma	6.11e-06	0.000772	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—C3—glaucoma	6.05e-06	0.000764	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NTRK1—glaucoma	6.04e-06	0.000764	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CDKN2B—glaucoma	5.81e-06	0.000735	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SMO—glaucoma	5.71e-06	0.000721	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SMO—glaucoma	5.69e-06	0.000719	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SMO—glaucoma	5.63e-06	0.000712	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—EDN1—glaucoma	5.58e-06	0.000705	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CDKN2B—glaucoma	5.57e-06	0.000704	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—C3—glaucoma	5.56e-06	0.000703	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—C3—glaucoma	5.55e-06	0.000701	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ABCA1—glaucoma	5.55e-06	0.000701	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CYP1B1—glaucoma	5.55e-06	0.000701	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—C3—glaucoma	5.49e-06	0.000694	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CA1—glaucoma	5.45e-06	0.000688	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EDN1—glaucoma	5.34e-06	0.000675	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CTSA—glaucoma	5.27e-06	0.000666	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NTRK2—glaucoma	5.22e-06	0.00066	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NTRK2—glaucoma	5.2e-06	0.000657	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NTRK2—glaucoma	5.15e-06	0.000651	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NGF—glaucoma	5.13e-06	0.000648	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CA2—glaucoma	4.98e-06	0.000629	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NGF—glaucoma	4.91e-06	0.00062	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—C3—glaucoma	4.87e-06	0.000616	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—C3—glaucoma	4.67e-06	0.00059	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—APOE—glaucoma	4.54e-06	0.000573	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CAV1—glaucoma	4.5e-06	0.000568	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NGFR—glaucoma	4.48e-06	0.000566	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NGFR—glaucoma	4.46e-06	0.000564	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—GSTM1—glaucoma	4.43e-06	0.00056	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NGFR—glaucoma	4.42e-06	0.000559	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—APOE—glaucoma	4.35e-06	0.000549	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CAV1—glaucoma	4.31e-06	0.000544	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—FN1—glaucoma	4.28e-06	0.000541	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NTRK1—glaucoma	4.25e-06	0.000538	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NTRK1—glaucoma	4.24e-06	0.000536	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—BAD—glaucoma	4.23e-06	0.000534	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NTRK1—glaucoma	4.2e-06	0.000531	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—FN1—glaucoma	4.1e-06	0.000518	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—BAD—glaucoma	4.05e-06	0.000512	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CDKN2B—glaucoma	3.92e-06	0.000495	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MTHFR—glaucoma	3.92e-06	0.000495	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CDKN2B—glaucoma	3.91e-06	0.000494	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CDKN2B—glaucoma	3.87e-06	0.000489	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EDN1—glaucoma	3.76e-06	0.000475	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EDN1—glaucoma	3.75e-06	0.000474	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EDN1—glaucoma	3.71e-06	0.000469	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—APOE—glaucoma	3.65e-06	0.000461	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CAV1—glaucoma	3.61e-06	0.000457	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—TXN—glaucoma	3.51e-06	0.000443	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NGF—glaucoma	3.46e-06	0.000437	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NGF—glaucoma	3.45e-06	0.000435	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NGF—glaucoma	3.41e-06	0.000431	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NOS3—glaucoma	3.4e-06	0.00043	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—C3—glaucoma	3.29e-06	0.000415	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—C3—glaucoma	3.28e-06	0.000414	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NOS3—glaucoma	3.26e-06	0.000411	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—C3—glaucoma	3.24e-06	0.00041	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APOE—glaucoma	3.06e-06	0.000387	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APOE—glaucoma	3.05e-06	0.000385	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CAV1—glaucoma	3.03e-06	0.000383	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CAV1—glaucoma	3.02e-06	0.000382	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APOE—glaucoma	3.02e-06	0.000382	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CAV1—glaucoma	2.99e-06	0.000378	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CDKN1B—glaucoma	2.95e-06	0.000372	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FN1—glaucoma	2.89e-06	0.000365	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FN1—glaucoma	2.88e-06	0.000363	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—BAD—glaucoma	2.85e-06	0.00036	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FN1—glaucoma	2.85e-06	0.00036	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—BAD—glaucoma	2.84e-06	0.000359	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CDKN1B—glaucoma	2.82e-06	0.000356	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—BAD—glaucoma	2.81e-06	0.000356	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—NOS3—glaucoma	2.73e-06	0.000345	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MMP9—glaucoma	2.73e-06	0.000345	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTT1—glaucoma	2.72e-06	0.000344	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MMP9—glaucoma	2.61e-06	0.00033	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGS2—glaucoma	2.5e-06	0.000316	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—VEGFA—glaucoma	2.45e-06	0.000309	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—VEGFA—glaucoma	2.35e-06	0.000296	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NOS3—glaucoma	2.29e-06	0.00029	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NOS3—glaucoma	2.29e-06	0.000289	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NOS3—glaucoma	2.26e-06	0.000286	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP1B1—glaucoma	2.17e-06	0.000274	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ABCA1—glaucoma	2.17e-06	0.000274	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CDKN1B—glaucoma	1.99e-06	0.000251	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CDKN1B—glaucoma	1.98e-06	0.00025	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CDKN1B—glaucoma	1.96e-06	0.000248	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TP53—glaucoma	1.85e-06	0.000234	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MMP9—glaucoma	1.84e-06	0.000232	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MMP9—glaucoma	1.83e-06	0.000232	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP9—glaucoma	1.82e-06	0.000229	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TP53—glaucoma	1.77e-06	0.000224	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTM1—glaucoma	1.73e-06	0.000219	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—VEGFA—glaucoma	1.65e-06	0.000209	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—VEGFA—glaucoma	1.65e-06	0.000208	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—VEGFA—glaucoma	1.63e-06	0.000206	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MTHFR—glaucoma	1.53e-06	0.000194	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOE—glaucoma	1.43e-06	0.00018	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CAV1—glaucoma	1.41e-06	0.000179	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TP53—glaucoma	1.25e-06	0.000158	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TP53—glaucoma	1.24e-06	0.000157	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TP53—glaucoma	1.23e-06	0.000156	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NOS3—glaucoma	1.07e-06	0.000135	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS2—glaucoma	9.77e-07	0.000123	CbGpPWpGaD
